14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $14.00 $25.40 Wednesday, 1st May 2024 DCPH stock ended at $25.36. This is 0.356% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 0.514% from a day low at $25.27 to a day high of $25.40.
90 days $13.86 $25.40
52 weeks $9.90 $25.40

Historical Deciphera Pharmaceuticals Inc prices

Date Open High Low Close Volume
Jul 17, 2023 $14.06 $14.45 $13.90 $13.90 330 442
Jul 14, 2023 $13.72 $14.03 $13.56 $14.01 469 447
Jul 13, 2023 $13.90 $14.05 $13.67 $13.69 381 549
Jul 12, 2023 $13.76 $13.97 $13.61 $13.89 310 465
Jul 11, 2023 $13.67 $13.67 $13.25 $13.60 357 132
Jul 10, 2023 $13.74 $13.96 $13.53 $13.69 464 646
Jul 07, 2023 $13.44 $13.77 $13.44 $13.76 352 567
Jul 06, 2023 $13.82 $13.82 $13.22 $13.45 373 647
Jul 05, 2023 $14.03 $14.12 $13.69 $13.89 514 795
Jul 03, 2023 $14.05 $14.14 $13.85 $14.04 165 466
Jun 30, 2023 $13.72 $14.38 $13.58 $14.08 553 110
Jun 29, 2023 $14.08 $14.16 $13.61 $13.61 538 398
Jun 28, 2023 $14.34 $14.34 $13.94 $14.04 508 226
Jun 27, 2023 $14.58 $14.61 $14.23 $14.26 357 819
Jun 26, 2023 $14.70 $14.70 $14.38 $14.54 363 654
Jun 23, 2023 $14.72 $14.84 $14.43 $14.73 763 227
Jun 22, 2023 $14.81 $14.99 $14.34 $14.77 412 834
Jun 21, 2023 $14.49 $14.94 $14.32 $14.91 490 775
Jun 20, 2023 $14.43 $14.56 $13.95 $14.52 958 451
Jun 16, 2023 $14.71 $14.71 $14.28 $14.43 779 183
Jun 15, 2023 $14.19 $14.60 $14.00 $14.54 372 260
Jun 14, 2023 $14.50 $14.70 $14.01 $14.18 340 289
Jun 13, 2023 $14.34 $14.87 $14.28 $14.50 738 066
Jun 12, 2023 $14.05 $14.27 $13.79 $14.02 404 153
Jun 09, 2023 $13.99 $14.10 $13.67 $14.02 462 210
Click to get the best stock tips daily for free!

About Deciphera Pharmaceuticals Inc

Deciphera Pharmaceuticals Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. Th... DCPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT